Form 4 for EVH Evolent Health, Inc.
Accepted 2022-08-04 00:00:00 ET · period of report 2022-08-01 · accession 0001628908-22-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-04 | 2022-08-01 | EVH | Shams Aammaad | CAO | A - Grant | $0.00 | +17.2K | 36.9K | +88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-01 | A | A | 17,247 | $0.00 | 36,884 | D | — | — | (F1) Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. (F2) Securities vest at a rate of 34% on August 1, 2023, and 33% on August 1, 2024, and August 1, 2025. (F3) Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. |